Literature DB >> 16380817

NKG2D in NK and T cell-mediated immunity.

Kouetsu Ogasawara1, Lewis L Lanier.   

Abstract

One of the best characterized NK cell receptors is NKG2D, a highly conserved C-type lectin-like membrane glycoprotein expressed on essentially all NK cells, as well as on gammadelta-TcR+ T cells and alphabeta-TcR+ CD8+ T cells, in humans and mice. Here we review recent studies implicating NKG2D in T cell and NK cell-mediated immunity to viruses and tumors, and its potential role in autoimmune diseases and allogeneic bone marrow transplantation.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16380817     DOI： 10.1007/s10875-005-8786-4

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN： 0271-9142            Impact factor:   8.317


  74 in total

1.  Cutting edge: novel priming of tumor-specific immunity by NKG2D-triggered NK cell-mediated tumor rejection and Th1-independent CD4+ T cell pathway.

Authors:  Jennifer A Westwood; Janice M Kelly; Jane E Tanner; Michael H Kershaw; Mark J Smyth; Yoshihiro Hayakawa
Journal:  J Immunol       Date:  2004-01-15       Impact factor: 5.422

2.  The role of the NKG2D immunoreceptor in immune cell activation and natural killing.

Authors:  Amanda M Jamieson; Andreas Diefenbach; Christopher W McMahon; Na Xiong; James R Carlyle; David H Raulet
Journal:  Immunity       Date:  2002-07       Impact factor: 31.745

3.  A cluster of ten novel MHC class I related genes on human chromosome 6q24.2-q25.3.

Authors:  Mirjana Radosavljevic; Benoît Cuillerier; Michael J Wilson; Oliver Clément; Sophie Wicker; Susan Gilfillan; Stephan Beck; John Trowsdale; Seiamak Bahram
Journal:  Genomics       Date:  2002-01       Impact factor: 5.736

4.  IL-21 enhances tumor rejection through a NKG2D-dependent mechanism.

Authors:  Rayna Takaki; Yoshihiro Hayakawa; Andrew Nelson; Pallavur V Sivakumar; Steven Hughes; Mark J Smyth; Lewis L Lanier
Journal:  J Immunol       Date:  2005-08-15       Impact factor: 5.422

5.  Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells.

Authors:  V Groh; R Rhinehart; J Randolph-Habecker; M S Topp; S R Riddell; T Spies
Journal:  Nat Immunol       Date:  2001-03       Impact factor: 25.606

6.  Natural killer cells determine the outcome of B cell-mediated autoimmunity.

Authors:  F D Shi; H B Wang; H Li; S Hong; M Taniguchi; H Link; L Van Kaer; H G Ljunggren
Journal:  Nat Immunol       Date:  2000-09       Impact factor: 25.606

7.  A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease.

Authors:  Sophie Hüe; Jean-Jacques Mention; Renato C Monteiro; ShaoLing Zhang; Christophe Cellier; Jacques Schmitz; Virginie Verkarre; Nassima Fodil; Seiamak Bahram; Nadine Cerf-Bensussan; Sophie Caillat-Zucman
Journal:  Immunity       Date:  2004-09       Impact factor: 31.745

8.  NKG2D blockade prevents autoimmune diabetes in NOD mice.

Authors:  Kouetsu Ogasawara; Jessica A Hamerman; Lauren R Ehrlich; Helene Bour-Jordan; Pere Santamaria; Jeffrey A Bluestone; Lewis L Lanier
Journal:  Immunity       Date:  2004-06       Impact factor: 31.745

9.  Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized.

Authors:  W J Murphy; V Kumar; M Bennett
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

10.  Peculiar immunobiology of bone marrow allografts. II. Rejection of parental grafts by resistant F 1 hybrid mice.

Authors:  G Cudkowicz; M Bennett
Journal:  J Exp Med       Date:  1971-12-01       Impact factor: 14.307
View more
  44 in total

1.  IL-10 induces aberrant deletion of dendritic cells by natural killer cells in the context of HIV infection.

Authors:  Galit Alter; Daniel Kavanagh; Suzannah Rihn; Rutger Luteijn; David Brooks; Michael Oldstone; Jan van Lunzen; Marcus Altfeld
Journal:  J Clin Invest       Date:  2010-05-03       Impact factor: 14.808

2.  EphA2 targeting peptide tethered bioreducible poly(cystamine bisacrylamide-diamino hexane) for the delivery of therapeutic pCMV-RAE-1γ to pancreatic islets.

Authors:  Katherine S Blevins; Ji Hoon Jeong; Mei Ou; Jonathan H Brumbach; Sung Wan Kim
Journal:  J Control Release       Date:  2011-10-28       Impact factor: 9.776

Review 3.  Cooperativity of adaptive and innate immunity: implications for cancer therapy.

Authors:  Anil Shanker; Francesco M Marincola
Journal:  Cancer Immunol Immunother       Date:  2011-06-09       Impact factor: 6.968

Review 4.  NKG2D ligands as therapeutic targets.

Authors:  Paul Spear; Ming-Ru Wu; Marie-Louise Sentman; Charles L Sentman
Journal:  Cancer Immun       Date:  2013-05-01

Review 5.  NKG2D and its ligands in cancer.

Authors:  Payal Dhar; Jennifer D Wu
Journal:  Curr Opin Immunol       Date:  2018-03-09       Impact factor: 7.486

6.  MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma.

Authors:  Masahisa Jinushi; Matthew Vanneman; Nikhil C Munshi; Yu-Tzu Tai; Rao H Prabhala; Jerome Ritz; Donna Neuberg; Kenneth C Anderson; Daniel Ruben Carrasco; Glenn Dranoff
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-17       Impact factor: 11.205

Review 7.  Signal transducer and activator of transcription 3: a year in review.

Authors:  Lisa R Forbes; Josh Milner; Elie Haddad
Journal:  Curr Opin Hematol       Date:  2016-01       Impact factor: 3.284

8.  The NKG2D ligands RAE-1δ and RAE-1ε differ with respect to their receptor affinity, expression profiles and transcriptional regulation.

Authors:  Oriane Cédile; Natalia Popa; Frédéric Pollet-Villard; Nicolas Garmy; El Chérif Ibrahim; José Boucraut
Journal:  PLoS One       Date:  2010-10-19       Impact factor: 3.240

9.  Biologic activity of irradiated, autologous, GM-CSF-secreting leukemia cell vaccines early after allogeneic stem cell transplantation.

Authors:  Vincent T Ho; Matthew Vanneman; Haesook Kim; Tetsuro Sasada; Yoon Joong Kang; Mildred Pasek; Corey Cutler; John Koreth; Edwin Alyea; Stefanie Sarantopoulos; Joseph H Antin; Jerome Ritz; Christine Canning; Jeffery Kutok; Martin C Mihm; Glenn Dranoff; Robert Soiffer
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-26       Impact factor: 11.205

10.  Polymeric delivery of therapeutic RAE-1 plasmid to the pancreatic islets for the prevention of type 1 diabetes.

Authors:  Wan Seok Joo; Ji Hoon Jeong; Kihoon Nam; Katherine S Blevins; Mohamed E Salama; Sung Wan Kim
Journal:  J Control Release       Date:  2012-08-14       Impact factor: 9.776
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.